World Rural Health Conference
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 1393
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents 
ORIGINAL ARTICLE
Year : 2019  |  Volume : 8  |  Issue : 2  |  Page : 717-721  

Evaluating the trend of cutaneous malignant tumors in Ilam from 2002 to 2011


1 Department of Pathology, Ilam University of Medical Sciences, Ilam; Biotechnology and Medical Plants Research Center, Ilam University of Medical Sciences, Ilam, Iran
2 Department of Medicine, Ilam University of Medical Sciences, Ilam, Iran
3 Department of Pathology, Clinical Research Development Center, Shahid Modarres Hospital, Tehran, Iran
4 Department of Cardiology, Ilam University of Medical Sciences, Ilam, Iran

Date of Web Publication28-Feb-2019

Correspondence Address:
Dr. Samiramis Ghavam
Department of Cardiology, Ilam University of Medical Sciences, Ilam
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jfmpc.jfmpc_178_17

Rights and Permissions
  Abstract 


Introduction: Skin cancer, the melanoma type of which causes high mortality, is the most common malignancy in Iran and all over the world. UV is the most important cause of the incidence of this disease. This study evaluates the frequency of different types of cancer and their trajectory in Ilam province from 2012 to 2011. Materials and Methods: This analytical–descriptive study covered and evaluated all skin cancer patients who were registered in Ilam Province Cancer Registry during 20002 to 2011. Required information of each individual patient, such as age, sex, residence, pathological type of skin cancer, the location of the incidence of the disorder, and the year, was collected and studied. Findings: Out of total 347 cases, 240 cases (69.2%) were diagnosed with basal cell carcinoma (BCC), 63 cases (18.2%) with squamous cell carcinoma (SCC), 16 cases (4.6%) with malignant melanoma (MM), 8 cases (2.3%) with metastatic cancer, and 20 cases (37.7%) with other skin cancers. Mean age of patients was 62/42 ± 16/11 years, and the majority of them (37.7%) were men and lived in the city. Face was the most common place of the incidence of this disease (81.6%) and hand was the least common one (1.7%). The rate of incidence of cancer has experienced considerable growth in men and a slight decrease in the case of women between 2002 and 2011 in Ilam. Conclusion: According to the results of this study, the rate of skin cancer has increased among men during the studied period; thus, necessary measures are required to prevent and reduce the incidence of this disease, especially in people who are exposed to the sun's ultraviolet rays because of their jobs.

Keywords: Basal cell carcinoma, Ilam, skin cancer, squamous cell carcinoma


How to cite this article:
Ahmadi MR, Bakhtari Z, Kazeminezhad B, Ghavam S. Evaluating the trend of cutaneous malignant tumors in Ilam from 2002 to 2011. J Family Med Prim Care 2019;8:717-21

How to cite this URL:
Ahmadi MR, Bakhtari Z, Kazeminezhad B, Ghavam S. Evaluating the trend of cutaneous malignant tumors in Ilam from 2002 to 2011. J Family Med Prim Care [serial online] 2019 [cited 2019 Aug 24];8:717-21. Available from: http://www.jfmpc.com/text.asp?2019/8/2/717/252988




  Introduction Top


Skin is the largest organ of the body that protects us against heat, light, and infection; it also helps in controlling body temperature, store water and fat, and produce vitamin D. Various cellular components of skin may change into malignancy. Skin cells grow and divide to take new forms. Cells age and die and new cells take their place; however, this orderly process sometimes goes wrong. Old cells do not die out and new cells grow when they are not actually needed in a specific part of the body. These extra cells form a mass of tissue called “tumor.” Skin cancer is one of the most common malignancies in the world.[1] According to World Health Organization report, issued in 2000, out of total 13,627,699 cases of cancers, 10,532,711 patients were diagnosed with basal cell carcinoma (BCC), 2,833,037 patients with squamous cell carcinoma (SCC), and 211,921 patients with malignant melanoma (MM). Skin cancer will have a significant impact on the overall disease load in the coming decades.[2] Several studies conducted in different countries across the world emphasize the increasing incidence of skin cancers. Reports issued from the UK, USA, and Australia show that cutaneous tumors are the most common human tumors; they also argue that BCC is the most common skin cancer.[3],[4] Skin cancer has a high rate of occurrence in old men of white race.[5],[6],[7] Although several genetic factors affect the incidence of skin cancer, type of skin and exposure to the sun are the most important factors in the development of skin cancer.[8] Nonmelanoma skin cancers, such as basal cell carcinoma and SCC, are the most common malignancy in America and most parts of the world; these disorders have experienced considerable growth in recent years.[9],[10],[11] According to official statistics, nonmelanoma skin cancer, the basic cause of incidence is exposure to sunlight, is one of the four most common cancers in adults.[12] A total of 1.3 million Americans are diagnosed with nonmelanoma cancers each year.[14] Although cancer rates are declining, skin cancer is rising at a rate of 3%–5%, despite being preventable and treatable, each year.[15] Our country is prone to experience increasing skin cancer rates because of severe sunlight in most seasons of the year, exposure of farmers, herdsmen, and construction workers to ultraviolet radiation, and failure to use appropriate protection such as hats, glasses, and clothing when working in an open environment.[16],[17] Based on what has been mentioned so far, this study was conducted to evaluate and assess the frequency and trajectory of malignant cutaneous tumors in Ilam during 2002 to 2011 to plan and implement more precise measure for preventing and treating various skin cancers.


  Materials And Methods Top


The sample size of this descriptive–analytical study included 347 subjects, all of whom were registered as suffering from skin cancers in Ilam Cancer registry between 2002 and 2011, with a confidence level of 95% and error rate of 5%. Required information of each individual patient, such as age, sex, residence, pathological type of skin cancer, the location of the incidence of the disorder, and the year, was collected and recorded in Excel. SPSS software, version 20, was used to conduct an analytical analysis of the data; confirmation of ethics committee was received before the initiation of the study.


  Findings Top


A total of 347 patients, including 227 (65.4%) male and 120 (34.6%) female subjects, were analyzed in this study; mean age of study participants was 62/42 ± 16/11 years, with a minimum age being 10 and maximum age being 110 years [Figure 1]. BCC had the highest frequency (69.2%). SCC, miscellaneous skin cancers, melanoma, and metastatic had a frequency of 18.2%, 5.8%, 4.6%, and 2.3%, respectively [Table 1]. In terms of the anatomical location of lesions, most to least common frequencies belonged to face (81.6%), body (7.5%), foot (5.2%), neck (4%), and hand (1.7%) [Table 1]. The statistical analysis showed that 63.7% of subjects resided in the city and urban areas; the incidence of cancer among all diseases was more prevalent in the city people in comparison with village people. According to the findings of this study, the highest incidence of malignant tumors transpires after the fifth decade of life, between 60 and 79 years, with a frequency of 156 subjects (45%) [Table 2]. Except for miscellaneous skin cancers, the incidence of cancer is more common among men rather than women in all types of skin cancers [Table 1] and [Figure 2]. Bowen's disease had the highest frequency among miscellaneous skin cancers (20 cases) [Table 3]. The maximum and minimum relative incidence was 71.2% and 50% in the case of BCC and 24% and 0% in terms of SCC, respectively [Table 4]. The rate of incidence of cancer has experienced considerable growth in men and a slight decrease in the case of women between 2002 and 2011 in Ilam.
Figure 1: Age frequency distribution of skin cancer patients in Ilam during 2002 to 2011

Click here to view
Table 1: The frequency distribution of clinical forms of cutaneous malignant tumors in terms of some variables

Click here to view
Table 2: The frequency distribution of clinical forms of cutaneous malignant tumors in terms of age groups

Click here to view
Figure 2: Sex-based growth of malignant cutaneous tumors during 2002 to 2011

Click here to view
Table 3: Frequency distribution of miscellaneous skin cancers

Click here to view
Table 4: Frequency distribution of cutaneous malignant tumors in terms of the year of incidence

Click here to view



  Discussion and Conclusion Top


This study, which lasted for 10 years, investigated an overall number of 347 patients. In terms of the frequency of the sex of subjects, the results of this study showed that men are diagnosed with skin cancer more than women, which is consistent with the findings of other research conducted around the world.[6],[7],[8],[9],[10],[11],[12],[13],[14],[15],[16],[17],[18] The results of studies carried out in Mashhad[1] and Hamedan[19] showed that basal cell carcinoma is more common in men with a rate of 4 and 1.8, respectively. Based on Yazdanfar study, BCC is a more common phenomenon among men in comparison with women.[20] The study which was conducted in Switzerland showed that BCC is more common among men in comparison with women.[21] The results of Abdol-Seied[22] and Ansarin study[23] indicated a higher incidence of BCC among men. Based on the findings of research conducted in Japan, BCC occurs with an equal rate among both sexes.[23] A study which was conducted in Bangkok on 67 patients showed that BCC is a more common phenomenon among women rather than men.[24] The main causes of the higher rate of skin cancer among men might be exposure to sunlight and ultraviolet radiation because of occupational necessities. According to Miler et al., hair follicles may play a role in the incidence of BCC. Boxman et al., discovered human papillomavirus DNA in isolated hair; they claimed that BCC can influence carcinogenesis;[25] thus, a difference in the dermal appendages, such as hair follicles, could make a difference in the incidence of BCC in both sexes. In terms of incidence age, the emergence of skin cancer is more common and probably in the sixth and seventh decades of life.[6],[26],[27],[28],[29],[30],[31] The incidence rate of BCC at the age of 40–79 years is 95%.[32] According to Collins et al.'s study, the mean age of patients suffering from BCC is 64 years in the Netherlands, which is consistent with the findings of this study.[33] The main causes of such a fact might be increased elderly population, skin type of the inhabitants of the region, the impact of environmental factors such as excessive exposure to the sun, late referral of patients to the doctor, increased awareness of younger generation of the dangers of sunlight, and decrease in professions, such as agriculture and raising animals among the younger generation. MM usually occurs at a younger age and this study reported 29–30 years of age as the highest frequency incidence age of these lesions. Based on the findings of a study conducted in Mashhad, the rate of the incidence of BCC, SCC, and MM was 57.7%, 20.2%, and 4.4%, respectively. The rate of the incidence of BCC was, for Yazd[16] and Isfahan,[17] 74% and 76%, respectively, in 1997. According to the Brisbane Pathology Center Report, 60% of 676 patients were diagnosed with BCC, 15% with SCC, and 4% with MM.[33],[34],[35] According to the results of studies conducted in the USA, the incidence rate of BCC was 75% among different types of skin cancer;[25],[26],[27] the incidence rate of BCC was, approximately, 79% in Australia;[6],[28],[31] such statistics are almost consistent with the findings of this study. BCC, SCC, and MM had the highest incidence rate.[6],[36] Based on the results of a study conducted in Mashhad, 93% of BCC lesions and 74% of SCC lesions occurred in the area of head and neck and extremities were the most common sites for the emergence of MM. Based on the results of a study conducted in Kerman, the incidence sites of SCC were head and neck in 77% of patients.[37] The most common, 81.6%, site of the incidence of skin cancer turned out to be face in this study. Because of being constantly exposed to severe sunlight, head and neck show to be more susceptible to skin abnormalities.[6],[26],[28],[31],[36],[38],[39],[40],[41],[42] Based on the results of this study, 63.7% of patients turned out to live in the city; the frequency of city people is more than that of village people in suffering from all kinds of skin cancers; however, considering the place of the conduction of this research, there are possibilities of bias. According to the results of this study, the rate of incidence of cancer has experienced considerable growth in men and a slight decrease in the case of women between 2002 and 2011; the main causes of such considerable difference of results might be usage of Islamic veil and prompt medical attention on the part of women and increased exposure to solar ultraviolet because of occupational reasons on the part of men. Skin cancer has become more common with increasing age; consequently, certain necessary measures must be implemented to prevent and reduce the incidence of such diseases, especially in individuals who are constantly exposed to solar ultraviolet because of occupational reasons.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Amouzgar MH, Yazdanpanah MJ, Ebrahimirad M. Frequency of different skin cancer in Qaem hospital of Mashhad, from 1975-1995. A cross-sectional study. Iran J Dermatol 2006;19:28-35.  Back to cited text no. 1
    
2.
Lucas R, McMichael T, Smith W, Armstrong B. Environmental Burden of Disease Series No. 13, Solar Ultraviolet Radiation: Global Burden of Disease from Solar Ultraviolet Radiation. World health organization; Geneva: 2006. p. 20-65.  Back to cited text no. 2
    
3.
Murphy GF, Mihm MC. Robbins' pathologic basis of disease, 5th Edition; New York: WB Saunders; 1994. p. 1174-8.  Back to cited text no. 3
    
4.
Sadler TW. Langmanes Medical Emberioligy. 6th ed. Philadelfia: WB Saunders; 1995. p. 19.  Back to cited text no. 4
    
5.
Leshin B, White WL. Malignant neoplasm's of keratinocytes. In: Arndt KA, Leboi PE, Robinson JK, Wintroub BU, editors. Cutaneous Medicine and Surgery. 1st ed. Philadelphia WB: Saunders Company; 1996. p. 1378-440.  Back to cited text no. 5
    
6.
Mackie RM, Quinin AG. Non-melanoma skin cancer and other epidermal skin tumors. Edited by: Tony Burns, Stephen Breathnach, Neil Cox, Christopher Griffiths. Wiley Blackwell Science Publication; Oxford: 2008. p. 36-50.  Back to cited text no. 6
    
7.
Ansing AC, Heintz AP. Epidemiology and etiology of squamous cell carcinoma of the vulva. Eur J Obstet Gynaecol Reprod Biol 1993;48:111-5.  Back to cited text no. 7
    
8.
Kricker A, Armstrong BK, English DR. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control 1994;5:367-92.  Back to cited text no. 8
    
9.
Quinn AG, Perkins W. Non- melanoma skin cancers and other epidermal skin tumor. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rooks Text Book of Dermatology. 8th ed, vol 36. Oxford: Wiley-Blackwell; 2010. p. 1-24.  Back to cited text no. 9
    
10.
Katz MH. Non-melanoma skin cancer. Md Med J 1997;46:239-42.  Back to cited text no. 10
    
11.
Eide MJ, Krajenta R, Johnson D, Long JJ, Jacobsen G, Asgari MM, et al. Identification of patients with nonmelanoma skin cancer using health maintenanco organization claims data. Am J Epid 2009;171:123-8.  Back to cited text no. 11
    
12.
Wheless L, Black J, Alberg AJ. Nonmelanoma skin cancer and the risk of second primary cancers: A systematic review. Cancer Epidemiol Biomarkers Prev 2010;19:1686-95.  Back to cited text no. 12
    
13.
Albert MR, Weinstock MA. Keratinocyte carcinoma. CA Cancer J Clin 2003;53:292-302.  Back to cited text no. 13
    
14.
Noorbala, Taghi M, Kafaie P. Analysis of 15 years of skin cancer in central Iran (Yazd). Dermatology Online Journal 2007:(4):1-4.  Back to cited text no. 14
    
15.
Mcclendon BT, Dunn SP. Reducing skin cancer risk: An intervention based on protection motivation theory. Journal of Health Psychology 2001;6:321-8.  Back to cited text no. 15
    
16.
Asilian U, Hassanpoor A, Meqdadi M. Consideration over the geographical prevalence of skin cancer in the center of Iran. Journal of Research in Medical Science 1997;2:65-8.  Back to cited text no. 16
    
17.
Noorbala M, Geti T. Concideration of skin cancer frequency in yazd. Puls 1995;4:15-20.  Back to cited text no. 17
    
18.
Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray JL. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2002;2:1471-2407.  Back to cited text no. 18
    
19.
Staples M, Marks R, Giles G. Trends in the incidence of non melanocytic skin cancer treated in Australia 1985-1995. Are primary prevention program stating to have an effect? Int J Cancer 1998;78:144-8.  Back to cited text no. 19
    
20.
Yazdanfar A, Ghasemi E. Frequency of skin cancers in Hamedan from 1991 to 2007. Dermatol Cosmet 2011:123-30. [Persian].  Back to cited text no. 20
    
21.
Bath-Hextall FJ, Perkins W, Bong J. Interven-tions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2007:CD003412. doi: 10.1002/14651858.CD003412.pub2.  Back to cited text no. 21
    
22.
Abdelsayed RA, Guijarro-Rojas M, Ibrahim NA, Sangueza OP. Immunohistochemical evaluation of basal cell carcinoma and trichepi-thelioma using Bcl-2, Ki67, PCNA and P53. J Cutan Pathol 2000;27:169-75.  Back to cited text no. 22
    
23.
Ansarin H, Daliri M, Soltani-Arabshahi R. Ex-pression of P53 in aggressive and nonaggressive histologic variants of basal cell carcinoma. Eur J Dermatol Cosmet 2006;16:543-7.  Back to cited text no. 23
    
24.
Bastiaens M, Hoefriagel J, Bruijn J, Westendorp RG, Vermeer BJ, Bouwes Bavinck JN. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinomas indicate different types of tumors. J Invest Dermatol 1998;110:880-4.  Back to cited text no. 24
    
25.
Kikuchi A, Shimizu H, Nishikawa T. Clinical histopathological characteritics of basal cell carcinoma in Japanese patients. Arch Dermatol 1996;132:320-4.  Back to cited text no. 25
    
26.
Nakiang Y, Kullavanijaya P. Basal cell carcinoma: Seven years experience at the Institute of Dermatology in Bangkok Thailand. J Dermatol 1994;21:660-3.  Back to cited text no. 26
    
27.
Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K. Fitzpatrick's Dermatology in General Medicine, 8th edition. New York: McGraw-Hill; 1999. p. 857-64.  Back to cited text no. 27
    
28.
Miller DL, Weinstack MA. Nonmelanoma skin cancer in United States: Incidence. J Am Acad Dermatol 1994;30:774-8.  Back to cited text no. 28
    
29.
Geller AC, Zhang Z, Sober AJ, Halpern AC, Weinstock MA, Daniels S, et al. The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. J Am Acad Dermatol 2003;48:34-41.  Back to cited text no. 29
    
30.
Guibert P, Mollat F, Ligen M, Dieno B. Melanoma screening. Arch Dermatol 2000;136:199-202.  Back to cited text no. 30
    
31.
Kennedy C, Bajdik CD. Descriptive epidemiology of skin cancer in Aruba: 1980-1999. Int J Dermatol 2001;40:169-74.  Back to cited text no. 31
    
32.
Gillos G. The incidence of non melanoma skin cancer in Australia. BMJ 1998;296:13-7.  Back to cited text no. 32
    
33.
Miller SJ. Biology of basal cell carcinoma (Part I). J Am Acad Dermatol 1991;24:1-13.  Back to cited text no. 33
    
34.
Coolins GL, Nickoonahand N, Morgan MB. Changing demographics and pathology of nonmelanoma skin cancer in the last 30 years. Semin Cutan Med Surg 2004;23:80-3.  Back to cited text no. 34
    
35.
Dahl E, Aberg M, Rausing A. Difined population. Cancer 1992;70:104-8.  Back to cited text no. 35
    
36.
Thomas JM. Premalignat and malignant epithelial tumors. In: Sams WM, Lynh PJ, editors. Principles and Practice of Dermatology. 1st ed. London: Churchill Livingstone; 1990. p. 200-4.  Back to cited text no. 36
    
37.
Schwartz RA, Stell HL, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, et al. Fitzpatrick's Dermatology in General Medicine. New York: Mc Graw Hill; 1999. p. 840-56.  Back to cited text no. 37
    
38.
Langely RG, Barnhill RL, Mihm MC, Fitzpatrick TB, Sober AJ. Cutaneous melanoma. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz S, editors. Fitzpatrick's Dermatology in General Medicine. USA: McGraw Hill; 1999. p. 1080-116.  Back to cited text no. 38
    
39.
Federman DG, Kravetz JD, Kirsner RS. Skin cancer screening by dermatologist: Prevalence and barriers. J Am Acad Dermatol 2002;46:710-4.  Back to cited text no. 39
    
40.
Farmer KC, Naylor MF. Sun Exposure sun screen and skin cancer prevention. J Am Pharmacother 1996;30:662-73.  Back to cited text no. 40
    
41.
Corona P, Dayliotti E, D'Errico M, Sera F, Iavarone I, Baliva G, et al. Risk factors for BCC in mediterranean population. Arch Dermatol 2001;137:1162-8.  Back to cited text no. 41
    
42.
Heymann WR. Skin cancer in African Americans. J Am Acad Dermatol 2005;53:484-5.  Back to cited text no. 42
    


    Figures

  [Figure 1], [Figure 2]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]



 

Top
   
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
   Abstract
  Introduction
   Materials And Me...
  Findings
   Discussion and C...
   References
   Article Figures
   Article Tables

 Article Access Statistics
    Viewed249    
    Printed4    
    Emailed0    
    PDF Downloaded25    
    Comments [Add]    

Recommend this journal